Shon Lo is an effective, versatile litigator with trial experience that spans the gamut of intellectual property infringement actions, including patent, trademark, copyright infringement, and trade secret misappropriation in federal district court and before the International Trade Commission (ITC). Shon has particular experience in representing biotech and pharmaceutical companies in patent litigation, including matters arising under the Hatch-Waxman Act.
Shon’s matters for generic and branded pharma and biotech companies involve both large and small molecule products including Dupixent®, Repatha®, Praluent®, Sernivo®, Toviaz®, and Nuvigil®, among others. Shon particularly enjoys advising clients about the patent, regulatory, and antitrust issues that arise in the context of pharmaceutical product development and subsequent litigation.
Shon is a registered patent attorney and conducts patent and trademark opinion work, counseling, and prosecution. She also conducts due diligence supporting corporate transactions. Shon’s clients and technical proficiency span many industries and sectors, including biotech, pharmaceuticals, medical devices, high-tech, entertainment, food products, consumer products, and household fixtures.
Shon began conducting research as an undergraduate and continued as a research technician and graduate student in various laboratories in the fields of molecular, cellular, and developmental biology and neurobiology at MIT, Stanford and the University of Chicago. In the course of her prior career as a scientist, Shon co-authored several scientific articles, including an article published in Science magazine.
Recognized, Litigation - Intellectual Property, Chicago, The Best Lawyers in America (2023)
Member, Practice Group of the Year, Intellectual Property, Law360 (2019)
Member, Litigation Department of the Year–Intellectual Property, The American Lawyer (2019)
Member, National Asian and Pacific American Bar Association